MELISSA HULL: Open Payments
NPI 1396181814 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,038 in 48 payments from 8 companies in 2025. Trend: 2023 $2,327 · 2024 $789 · 2025 $1,038
Food & beverage: $1,038
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $343 |
| PFIZER INC. | 22 | $261 |
| SK Life Science, Inc. | 3 | $252 |
| ARGENX US, INC. | 1 | $80 |
| Averitas Pharma Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
Products named: NURTEC ODT, QULIPTA, UBRELVY, VYVGART, BOTOX, QUTENZA, KESIMPTA, ULTOMIRIS.
Industry payments across TX — which companies pay providers there.
